Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Ajax Therapeutics is a biotechnology company developing therapies to target cytokine signaling pathways that drive hematologic malignancies.
ITeos Therapeutics is a biotechnology company that specializes in tumor immunology, cancer immunotherapy, and drug discovery.
Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.
Asher Bio is a biotechnology company that specializes in the fields of therapeutics builds better immunotherapy for cancer.
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
SeLux Diagnostics is a developer of a next-generation phenotyping platform that provides personalized antimicrobial therapies to patients.
Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment.
Nkarta Therapeutics is a developer of cell engineering platform created to build the next generation of cell therapies.
Capstan Therapeutics develops in vivo mRNA and gene-editing medicines for a broad range of diseases.
Unicycive Therapeutics provides development programs that focus on treating kidney diseases with unmet medical needs.
NAPIGEN is a biotechnology company that addresses novel genome engineering of various organisms such as plants, microbes, and animals.
Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).
Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs.
ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.
Tourmaline Bio is a biotechnology company that develops medicines to treat inflammatory and immune diseases in patients.
Verve Therapeutics is a clinical-stage biotechnology company developing genetic medicines for cardiovascular disease.
Forward Therapeutics is a biopharma comapny targeting treatment of chronic inflammatory disorders.
Aiolos Bio is a biotech company developing innovative therapies for respiratory diseases and immune conditions.
Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases.
Harpoon Therapeutics is a clinical-stage immunotherapy company focused on the development of novel T-cell recruiting biologic therapies.
Ventricle Health offers evidence-based therapy, remote patient monitoring, patient education, and advocacy services for cardiac care.
Cerevel Therapeutics is a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric disorders.
HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines.
RA Capital Management has invested in 467 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
RA Capital Management's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 14 different industry categories.
Among tracked funding rounds, Cerevel Therapeutics received $450.0M in a Post-IPO Equity round. RA Capital Management's total known invested capital is $56.7B.
RA Capital Management's average investment size is $123.5M across its portfolio of 467 companies.
Recent RA Capital Management portfolio additions include Ajax Therapeutics, ITeos Therapeutics, Bluejay Therapeutics, Asher Bio, Acrivon Therapeutics. These companies were founded in 2020 or later.